CLKB Pharmaceuticals Private Limited
About CLKB Pharmaceuticals Private Limited
Data last updated:
CLKB Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 17 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2017PTC289656. Its GSTIN is 27AAGCC8096B1ZK (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sundar Chandrasekaran and Bhuvaneswari Chandrasekaran.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 402 Serenity Raheja Reflections Magathane, Mumbai, Maharashtra, India – 400066.
As per the financials filed for FY 2025, the company reported a revenue of ₹45,683, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹315 (net margin 0.7%) and EBITDA of ₹315 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
CLKB Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressB – 402 Serenity Raheja Reflections Magathane, Mumbai, Maharashtra, India – 400066
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of CLKB Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of CLKB Pharmaceuticals Private Limited
FY 2025 filings availableCLKB Pharmaceuticals Private Limited reported revenue of ₹45,683 (up 154% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over three years, including 154% growth in the latest year. EBITDA rose 139% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹315 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹315 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of CLKB Pharmaceuticals Private Limited, buy the company report.
Board of directors of CLKB Pharmaceuticals Private Limited
CLKB Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sundar Chandrasekaran | Director | 17 Jan 2017 | 9 Years 9 Months | Current |
| Bhuvaneswari Chandrasekaran | Director | 17 Jan 2017 | 9 Years 9 Months | Current |
Peer comparison
CLKB Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr. Remedies Pharmaceuticals Private Limited | ₹47,255 (FY 2025) | Hyderabad, Telangana, India | ||||
| International Genetics Pharmaceuticals (OPC) Private Limited | ₹47,210 (FY 2025) | -34.0% | Indore, Madhya Pradesh, India | |||
| Tutis Pharmaceuticals Private Limited | ₹47,148 (FY 2020) | -84.0% | Kozhikode, Kerala, India | |||
| Chiga Pharmaceuticals Private Limited | ₹46,516 (FY 2024) | 498.0% | Bettiah, Bihar, India | |||
| Healto Pharmaceuticals Private Limited | ₹46,290 (FY 2022) | Hyderabad, Telangana, India | ||||
| CLKB Pharmaceuticals Private Limitedthis company | ₹45,683 (FY 2025) | ₹315 | 0.7% | 154.0% | Mumbai, Maharashtra, India | |
| Rachael Pharmaceuticals Private Limited | ₹45,666 (FY 2024) | Hyderabad, Telangana, India | ||||
| Roffton Pharmaceuticals Private Limited | ₹45,165 (FY 2025) | -82.0% | Delhi, India | |||
| VSN Pharmaceuticals Private Limited | ₹45,110 (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Activebio Pharmaceuticals Private Limited | ₹45,000 (FY 2017) | New Delhi, Delhi, India | ||||
| Bovetas Pharmaceuticals Private Limited | ₹45,000 (FY 2019) | -90.0% | Delhi, India |
To see the full peer comparison of CLKB Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving CLKB Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for CLKB Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
CLKB Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCC8096B1ZK | Maharashtra | Active | 24 Oct 2019 |
To see the full GST registrations and return filing status of CLKB Pharmaceuticals Private Limited, buy the company report.
Recent activity
CLKB Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Bhuvaneswari Chandrasekaran was appointed as Director on 17 Jan 2017.
Frequently asked questions
CLKB Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 17 January 2017 (9+ years old) and is registered under CIN U24304MH2017PTC289656.
CLKB Pharmaceuticals has 2 current directors:
- Sundar Chandrasekaran - Director
- Bhuvaneswari Chandrasekaran - Director
The latest financial statements of CLKB Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of CLKB Pharmaceuticals is 27AAGCC8096B1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of CLKB Pharmaceuticals is U24304MH2017PTC289656. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
CLKB Pharmaceuticals was incorporated on 17 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of CLKB Pharmaceuticals by revenue are Dr. Remedies Pharmaceuticals Private Limited, International Genetics Pharmaceuticals (OPC) Private Limited, Tutis Pharmaceuticals Private Limited, Chiga Pharmaceuticals Private Limited, Healto Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Bhuvaneswari Chandrasekaran was appointed as Director on 17 Jan 2017. Sundar Chandrasekaran was appointed as Director on 17 Jan 2017.
The registered office of CLKB Pharmaceuticals is at B – 402 Serenity Raheja Reflections Magathane, Mumbai, Maharashtra, India – 400066.
CLKB Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
The compliance status of CLKB Pharmaceuticals is compliant as of 27 September 2026. The company is actively filing with the Registrar of Companies.